UNICA IRIS Institutional Research Information System

MASSA, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 140.263
NA - Nord America 10.917
AS - Asia 4.056
SA - Sud America 652
AF - Africa 79
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 155.990
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 137.462
US - Stati Uniti d'America 10.770
CN - Cina 1.822
SG - Singapore 1.485
UA - Ucraina 957
SE - Svezia 636
BR - Brasile 542
DE - Germania 301
GB - Regno Unito 286
FI - Finlandia 266
VN - Vietnam 236
KR - Corea 141
FR - Francia 109
CA - Canada 91
IN - India 68
HK - Hong Kong 61
AR - Argentina 44
MX - Messico 39
AT - Austria 36
TR - Turchia 35
ZA - Sudafrica 34
NL - Olanda 33
IR - Iran 30
RU - Federazione Russa 28
PL - Polonia 25
BD - Bangladesh 24
BE - Belgio 23
JP - Giappone 23
ID - Indonesia 20
ES - Italia 19
EC - Ecuador 17
IE - Irlanda 16
IQ - Iraq 16
CZ - Repubblica Ceca 14
PK - Pakistan 13
AU - Australia 11
CL - Cile 11
PY - Paraguay 10
CO - Colombia 9
KE - Kenya 9
TW - Taiwan 9
PE - Perù 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
EU - Europa 7
MA - Marocco 7
RO - Romania 7
UZ - Uzbekistan 7
LT - Lituania 6
PH - Filippine 6
TN - Tunisia 6
BO - Bolivia 5
DK - Danimarca 5
LV - Lettonia 5
NP - Nepal 5
AM - Armenia 4
CH - Svizzera 4
IL - Israele 4
JO - Giordania 4
KZ - Kazakistan 4
OM - Oman 4
PT - Portogallo 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GR - Grecia 3
JM - Giamaica 3
KG - Kirghizistan 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
UG - Uganda 3
UY - Uruguay 3
VE - Venezuela 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
CR - Costa Rica 2
HU - Ungheria 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
ML - Mali 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AQ - Antartide 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DJ - Gibuti 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
Totale 155.977
Salva come PNG Salva come JPEG
Città #
Cagliari 132.572
Uta 4.219
Fairfield 1.168
Woodbridge 1.021
Ashburn 895
Houston 829
Singapore 714
Chandler 670
Dallas 608
Jacksonville 555
Boardman 551
Seattle 499
Wilmington 482
Ann Arbor 480
Nyköping 461
Cambridge 413
Beijing 332
Dearborn 257
Nanjing 171
Hefei 158
Santa Clara 148
Los Angeles 147
Boston 144
Seoul 130
New York 129
Shanghai 113
Helsinki 99
Buffalo 98
San Diego 90
Ho Chi Minh City 88
Guangzhou 81
Milan 72
The Dalles 67
Nanchang 57
Hong Kong 56
Munich 53
Shenyang 48
Hebei 42
Toronto 42
London 41
Hangzhou 40
Hanoi 40
Redondo Beach 40
São Paulo 40
Changsha 38
Redwood City 36
Chicago 34
Jiaxing 34
Tianjin 33
Verona 32
Jinan 30
Rome 29
Norwalk 28
Nuremberg 28
Orange 26
Rio de Janeiro 23
Warsaw 22
Brussels 21
Pune 20
Auburn Hills 19
Frankfurt am Main 18
Mountain View 18
Tokyo 18
Turku 18
Vienna 18
Zhengzhou 18
Atlanta 17
Johannesburg 17
Kunming 17
Phoenix 17
Brooklyn 16
Sassari 16
Belo Horizonte 15
Council Bluffs 15
Dublin 15
Wuhan 15
Amsterdam 14
Stockholm 14
Mexico City 13
San Mateo 13
Chennai 12
Dong Ket 12
Montreal 12
Ningbo 12
Ankara 11
Denver 11
San Francisco 11
Campinas 10
Kilburn 10
Taizhou 10
Augusta 9
Brasília 9
Elk Grove Village 9
Istanbul 9
Manchester 9
Naples 9
Ninh Bình 9
Shenzhen 9
Baghdad 8
Berlin 8
Totale 149.934
Salva come PNG Salva come JPEG
Nome #
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 4.838
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.941
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.913
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.792
Molecular-biology-driven treatment for metastatic colorectal cancer 2.717
Sense of coherence and physical health-related quality of life in Italian chronic patients: The mediating role of the mental component 2.655
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.587
CREAM study: Clinical correlation between ipilimumab-Related colitis And intestinal Microbiote in metastatic melanoma patients 2.544
Alcohol consumption is a modifiable risk factor for breast cancer: Are women aware of this relationship? 2.539
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.405
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.303
Health related quality of life in patients with onco-hematological diseases 2.190
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 2.167
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.842
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial 1.820
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.755
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial 1.744
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer 1.716
The nutritional risk in oncology: a study of 1,453 cancer outpatients 1.706
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.686
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.683
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.650
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.648
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care) 1.629
The Quality of Life of People with Solid Cancer is Less Worse than Other Diseases with better Prognosis, Except in the Presence of Depression 1.610
Weight loss in cancer patients: a plea for a better awareness of the issue 1.570
Active elderly and health—can moderate exercise improve health and wellbeing in older adults? Protocol for a randomized controlled trial 1.557
Immunotherapy and Cancer: The Multi-Omics Perspective 1.556
Case-control Phase ii clinical trial to assess efficacy and safety, of the same antineoplastic treatment(s) in elderly "fit" compared to adult patients with cancer at different sites 1.534
null 1.489
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause 1.486
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.485
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.463
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia = Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: Final analysis of GIDEON study in Italy 1.451
null 1.306
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.287
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.266
Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens 1.190
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.155
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.136
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 1.118
Risultati preliminari di uno studio di fase II con Sorafenib in pazienti anziani affetti da epatocarcinoma 1.054
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 1.021
PAX8 Positivity, Abnormal p53 Expression, and p16 Negativity in a Primary Endometrial Squamous Cell Carcinoma: A Case Report and Review of the Literature 998
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study 986
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 977
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 959
null 944
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response 928
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer 926
An attempt to correlate a "Multidimensional Geriatric Assessment" (MGA), treatment assignment and clinical outcome in elderly cancer patients: results of a phase II open study 918
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients 905
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial 895
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer 863
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 819
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 777
Association of serum IL-6 levels with comprehensive geriatric assessment variables in a population of elderly cancer patients 777
ALCOL E TUMORE ALLA MAMMELLA 771
null 768
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 768
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 766
Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report 761
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 761
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 754
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 743
Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment 736
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 722
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 714
null 709
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 702
null 694
Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy 694
null 688
null 681
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2 679
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 676
Early epirubicin (EPI)-induced myocardial dysfunction revealed by serial tissue doppler imaging (TDI): Correlation with inflammatory and oxidative stress markers 670
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 668
Risk factors for sentinel lymph node involvement in patients with apparent early-stage endometrial cancer: a retrospective single-center study 636
HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review 626
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites 607
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 605
Managing cancer-related anorexia/cachexia 599
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 599
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity 595
Cancer-related cachexia and oxidative stress: beyond current therapeutic options 585
Low adherence to therapy and co-morbid depressive episodes are independent determinants of early death in people with cancer 580
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 580
Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer 577
null 572
Early Strain Rate impairment during treatment with epirubicin is associated with high levels of reactive oxygen species 562
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression 560
p16 Block Type Overexpression, p53 Wild Type Reactivity, and Cervical Involvement do not Always Exclude the Diagnosis of Primary Endometrial Squamous Cell Carcinoma (PESCC) 555
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites 555
Serum levels of leptin and proinflammatory cytokines in patients with advanced stage cancer at different sites 554
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes 541
A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 538
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS): Interim results 536
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 533
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma 530
Totale 120.626
Salva come PNG Salva come JPEG
Categoria #
all - tutte 221.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 221.451
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116.038 0 0 0 0 0 4.884 3.622 2.503 803 1.576 1.532 1.118
2021/20226.510 644 561 269 475 659 449 288 343 557 484 799 982
2022/202311.806 923 1.351 1.172 1.019 1.030 1.197 556 1.411 813 758 994 582
2023/202415.649 1.344 532 508 998 1.552 3.150 1.551 1.008 770 1.333 1.489 1.414
2024/202533.171 7.154 9.157 4.077 3.895 2.005 3.729 1.402 179 440 308 380 445
2025/20264.457 583 551 1.233 874 759 457 0 0 0 0 0 0
Totale 156.345